NCT06327971View on ClinicalTrials.gov

Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology

Active, not recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 20, 2023

Primary Completion Date

October 31, 2028

Study Completion Date

October 31, 2028

Conditions
Squamous Cell Carcinoma of the Skin
Trial Locations (1)

Unknown

Barts Health NHS Trust, London

All Listed Sponsors
lead

Queen Mary University of London

OTHER

NCT06327971 - Enhanced Outcome Prediction in Cutaneous Squamous Cell Carcinoma Using Deep-learning and Computational Histopathology | Biotech Hunter | Biotech Hunter